Total Payments
$584.77
2024 Payments
$34.98
Companies
6
Transactions
13
Medicare Patients
2,324
Medicare Billing
$177,540
Payment Breakdown by Category
Food & Beverage$584.77 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $584.77 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $155.80 | 7 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $120.83 | 1 | $0 (2023) |
| Grifols USA, LLC | $107.14 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $88.02 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $78.00 | 1 | $0 (2019) |
| ABBVIE INC. | $34.98 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.98 | 2 | ABBVIE INC. ($34.98) |
| 2023 | $120.83 | 1 | Regeneron Healthcare Solutions, Inc. ($120.83) |
| 2020 | $155.80 | 7 | Teva Pharmaceuticals USA, Inc. ($155.80) |
| 2019 | $273.16 | 3 | Grifols USA, LLC ($107.14) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $120.83 | General |
| 12/09/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: Central Nervous System | ||||||
| 10/06/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Central Nervous System | ||||||
| 09/21/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Central Nervous System | ||||||
| 09/09/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Central Nervous System | ||||||
| 07/31/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Central Nervous System | ||||||
| 05/26/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Central Nervous System | ||||||
| 02/11/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: Central Nervous System | ||||||
| 09/18/2019 | Novartis Pharmaceuticals Corporation | FEVIPIPRANT (Drug) | Food and Beverage | In-kind items and services | $78.00 | General |
| 06/20/2019 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $107.14 | General |
| Category: Pulmonology | ||||||
| 03/26/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $88.02 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 564 | 652 | $134,785 | $39,826 |
| 2022 | 4 | 585 | 721 | $143,665 | $44,449 |
| 2021 | 5 | 501 | 666 | $138,579 | $45,561 |
| 2020 | 7 | 674 | 877 | $175,265 | $47,705 |
Total Patients
2,324
Total Services
2,916
Medicare Billing
$177,540
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 221 | $41,548 | $14,051 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 120 | 155 | $34,410 | $9,660 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 53 | $18,020 | $5,353 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $15,496 | $4,822 | 31.1% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 39 | 39 | $7,683 | $2,157 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 37 | $4,736 | $1,862 | 39.3% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Facility | 2023 | 11 | 11 | $2,376 | $626.12 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $1,788 | $613.68 | 34.3% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 56 | 56 | $5,656 | $571.68 | 10.1% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Facility | 2023 | 16 | 16 | $3,072 | $109.62 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 307 | $57,784 | $20,545 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 121 | 179 | $39,670 | $11,819 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $17,284 | $5,509 | 31.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 39 | $13,260 | $4,024 | 30.3% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 119 | 119 | $12,019 | $2,191 | 18.2% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Facility | 2022 | 18 | 19 | $3,648 | $361.00 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 209 | 304 | $57,254 | $21,607 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 129 | 196 | $43,512 | $12,637 | 29.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $16,390 | $5,184 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 33 | $11,220 | $3,548 | 31.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 15 | $3,840 | $1,564 | 40.7% |
| 96136 | Psychological or neuropsychological test administration and scoring by qualified health care professional, first 30 minutes | Office | 2021 | 63 | 63 | $6,363 | $1,020 | 16.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 196 | 281 | $52,916 | $13,990 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 145 | 209 | $46,066 | $12,917 | 28.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 53 | 53 | $15,365 | $4,775 | 31.1% |
About Cheryl Bernstein
Cheryl Bernstein is a Specialist healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760454805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cheryl Bernstein has received a total of $584.77 in payments from pharmaceutical and medical device companies, with $34.98 received in 2024. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($584.77).
As a Medicare-enrolled provider, Bernstein has provided services to 2,324 Medicare beneficiaries, totaling 2,916 services with total Medicare billing of $177,540. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Pittsburgh, PA
- Active Since 02/03/2006
- Last Updated 04/06/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1760454805
Products in Payments
- AJOVY (Biological) $155.80
- Prolastin-C (Biological) $107.14
- FASENRA (Drug) $88.02
- FEVIPIPRANT (Drug) $78.00
- UBRELVY (Drug) $20.44
- QULIPTA (Drug) $14.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pittsburgh
Dr. Lawrence Crossett, Md, MD
Specialist — Payments: $5.3M
Specialist $5.3M
Dr. James Bradley, Md, MD
Specialist — Payments: $5.0M
Specialist $5.0M
Darrell Triulzi
Specialist — Payments: $3.3M
Specialist $3.3M
Dr. Mark Yazer, Md, MD
Specialist — Payments: $2.4M
Specialist $2.4M
Lirong Qu
Specialist — Payments: $2.4M
Specialist $2.4M
Dr. Miguel Regueiro, Md, MD
Specialist — Payments: $1.4M
Specialist $1.4M